Eric Simpson, MD, MCR

home / authors / eric-simpson-md-mcr

Articles

Eric Simpson, MD, Discusses Recently Announced EADV Data On Tapinarof Cream for AD Down to 2 Years

Eric Simpson, MD, Discusses Recently Announced EADV Data On Tapinarof Cream for AD Down to 2 Years

Kaitlyn Bader, Senior Editor ;Eric Simpson, MD, MCR

October 12th 2023

New data from ADORING 1 and ADORING 2 show a rapid reduction in pruritus relief as early as 24 hours after the first application.

Latest Updated Articles

2 KOLs are featured in this series.

Published: September 19th 2024 | Updated: September 26th 2024

Final Thoughts: The Importance of Comparative Studies in AD

POLL: Which of the Following 2023 NP & PA Conferences Has Been Your Favorite?

Published: November 7th 2023 | Updated: April 1st 2025

POLL: Which of the Following 2023 NP & PA Conferences Has Been Your Favorite?

Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters

Published: March 11th 2025 | Updated: April 1st 2025

Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters

Apoptosis-Based Skin Cancer Treatment Shows Promise

Published: March 15th 2025 | Updated: April 1st 2025

Apoptosis-Based Skin Cancer Treatment Shows Promise

Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin Health

Published: March 7th 2025 | Updated: April 1st 2025

Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin Health

Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD

Published: March 8th 2025 | Updated: April 1st 2025

Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD

Recent Content

Optimizing Vitiligo Care: Key Expert Takeaways

Optimizing Vitiligo Care: Key Expert Takeaways

Dermatology Conferences and Meetings Calendar: April 2025

Dermatology Conferences and Meetings Calendar: April 2025

Daily Derm Times: March 31, 2025

Daily Derm Times: March 31, 2025

Patients with Vitiligo Have a Lower Risk of Developing Serious Infections, New Poster Finds

Patients with Vitiligo Have a Lower Risk of Developing Serious Infections, New Poster Finds

View More Recent Content

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.